Activation of the wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models

Ying Chen, Yang Hu, Ti Zhou, Kevin K. Zhou, Robert Mott, Mingyuan Wu, Michael Boulton, Timothy J. Lyons, Guoquan Gao, Jian Xing Ma

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Although Wnt signaling is known to mediate multiple biological and pathological processes, its association with diabetic retinopathy (DR) has not been established. Here we show that retinal levels and nuclear translocation of β-catenin, a key effector in the canonical Wnt pathway, were increased in humans with DR and in three DR models. Retinal levels of lowdensity lipoprotein receptor-related proteins 5 and 6, coreceptors of Wnts, were also elevated in the DR models. The high glucose-induced activation of β-catenin was attenuated by aminoguanidine, suggesting that oxidative stress is a direct cause for the Wnt pathway activation in diabetes. Indeed, Dickkopf homolog 1, a specific inhibitor of the Wnt pathway, ameliorated retinal inflammation, vascular leakage, and retinal neovascularization in the DR models. Dickkopf homolog 1 also blocked the generation of reactive oxygen species induced by high glucose, suggesting that Wnt signaling contributes to the oxidative stress in diabetes. These observations indicate that the Wnt pathway plays a pathogenic role in DR and represents a novel therapeutic target.

Original languageEnglish (US)
Pages (from-to)2676-2685
Number of pages10
JournalAmerican Journal of Pathology
Volume175
Issue number6
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Wnt Signaling Pathway
Diabetic Retinopathy
Animal Models
Catenins
Low Density Lipoprotein Receptor-Related Protein-6
Low Density Lipoprotein Receptor-Related Protein-5
Oxidative Stress
Retinal Neovascularization
Biological Phenomena
Glucose
Retinal Vessels
Pathologic Processes
Reactive Oxygen Species
Inflammation

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Activation of the wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. / Chen, Ying; Hu, Yang; Zhou, Ti; Zhou, Kevin K.; Mott, Robert; Wu, Mingyuan; Boulton, Michael; Lyons, Timothy J.; Gao, Guoquan; Ma, Jian Xing.

In: American Journal of Pathology, Vol. 175, No. 6, 2009, p. 2676-2685.

Research output: Contribution to journalArticle

Chen, Y, Hu, Y, Zhou, T, Zhou, KK, Mott, R, Wu, M, Boulton, M, Lyons, TJ, Gao, G & Ma, JX 2009, 'Activation of the wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models', American Journal of Pathology, vol. 175, no. 6, pp. 2676-2685. https://doi.org/10.2353/ajpath.2009.080945
Chen, Ying ; Hu, Yang ; Zhou, Ti ; Zhou, Kevin K. ; Mott, Robert ; Wu, Mingyuan ; Boulton, Michael ; Lyons, Timothy J. ; Gao, Guoquan ; Ma, Jian Xing. / Activation of the wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. In: American Journal of Pathology. 2009 ; Vol. 175, No. 6. pp. 2676-2685.
@article{2587c714d148425aacab392ce7e93a4d,
title = "Activation of the wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models",
abstract = "Although Wnt signaling is known to mediate multiple biological and pathological processes, its association with diabetic retinopathy (DR) has not been established. Here we show that retinal levels and nuclear translocation of β-catenin, a key effector in the canonical Wnt pathway, were increased in humans with DR and in three DR models. Retinal levels of lowdensity lipoprotein receptor-related proteins 5 and 6, coreceptors of Wnts, were also elevated in the DR models. The high glucose-induced activation of β-catenin was attenuated by aminoguanidine, suggesting that oxidative stress is a direct cause for the Wnt pathway activation in diabetes. Indeed, Dickkopf homolog 1, a specific inhibitor of the Wnt pathway, ameliorated retinal inflammation, vascular leakage, and retinal neovascularization in the DR models. Dickkopf homolog 1 also blocked the generation of reactive oxygen species induced by high glucose, suggesting that Wnt signaling contributes to the oxidative stress in diabetes. These observations indicate that the Wnt pathway plays a pathogenic role in DR and represents a novel therapeutic target.",
author = "Ying Chen and Yang Hu and Ti Zhou and Zhou, {Kevin K.} and Robert Mott and Mingyuan Wu and Michael Boulton and Lyons, {Timothy J.} and Guoquan Gao and Ma, {Jian Xing}",
year = "2009",
doi = "10.2353/ajpath.2009.080945",
language = "English (US)",
volume = "175",
pages = "2676--2685",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Activation of the wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models

AU - Chen, Ying

AU - Hu, Yang

AU - Zhou, Ti

AU - Zhou, Kevin K.

AU - Mott, Robert

AU - Wu, Mingyuan

AU - Boulton, Michael

AU - Lyons, Timothy J.

AU - Gao, Guoquan

AU - Ma, Jian Xing

PY - 2009

Y1 - 2009

N2 - Although Wnt signaling is known to mediate multiple biological and pathological processes, its association with diabetic retinopathy (DR) has not been established. Here we show that retinal levels and nuclear translocation of β-catenin, a key effector in the canonical Wnt pathway, were increased in humans with DR and in three DR models. Retinal levels of lowdensity lipoprotein receptor-related proteins 5 and 6, coreceptors of Wnts, were also elevated in the DR models. The high glucose-induced activation of β-catenin was attenuated by aminoguanidine, suggesting that oxidative stress is a direct cause for the Wnt pathway activation in diabetes. Indeed, Dickkopf homolog 1, a specific inhibitor of the Wnt pathway, ameliorated retinal inflammation, vascular leakage, and retinal neovascularization in the DR models. Dickkopf homolog 1 also blocked the generation of reactive oxygen species induced by high glucose, suggesting that Wnt signaling contributes to the oxidative stress in diabetes. These observations indicate that the Wnt pathway plays a pathogenic role in DR and represents a novel therapeutic target.

AB - Although Wnt signaling is known to mediate multiple biological and pathological processes, its association with diabetic retinopathy (DR) has not been established. Here we show that retinal levels and nuclear translocation of β-catenin, a key effector in the canonical Wnt pathway, were increased in humans with DR and in three DR models. Retinal levels of lowdensity lipoprotein receptor-related proteins 5 and 6, coreceptors of Wnts, were also elevated in the DR models. The high glucose-induced activation of β-catenin was attenuated by aminoguanidine, suggesting that oxidative stress is a direct cause for the Wnt pathway activation in diabetes. Indeed, Dickkopf homolog 1, a specific inhibitor of the Wnt pathway, ameliorated retinal inflammation, vascular leakage, and retinal neovascularization in the DR models. Dickkopf homolog 1 also blocked the generation of reactive oxygen species induced by high glucose, suggesting that Wnt signaling contributes to the oxidative stress in diabetes. These observations indicate that the Wnt pathway plays a pathogenic role in DR and represents a novel therapeutic target.

UR - http://www.scopus.com/inward/record.url?scp=73549107654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73549107654&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2009.080945

DO - 10.2353/ajpath.2009.080945

M3 - Article

VL - 175

SP - 2676

EP - 2685

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 6

ER -